Updated interim analysis from Keynote-057: Pembrolizumab monotherapy for patients with high-risk non-muscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG) Meeting Abstract
| Authors: | Krieger, L.; de Wit, R.; Kulkarni, G. S.; Uchio, E. M.; Boormans, J. L.; Roumiguie, M.; Singer, E. A.; Bajorin, D. F.; Kamat, A. M.; Grivas, P.; Seo, H. K.; Nishiyama, H.; Konety, B. R.; Nam, K.; Kapadia, E.; Frenkl, T. L.; Balar, A. V. |
| Abstract Title: | Updated interim analysis from Keynote-057: Pembrolizumab monotherapy for patients with high-risk non-muscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG) |
| Meeting Title: | 2019 Annual Scientific Meeting of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 15 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Jul 21-23 |
| Meeting Location: | Brisbane, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-07-01 |
| Start Page: | 52 |
| End Page: | 53 |
| Language: | English |
| ACCESSION: | WOS:000476915200039 |
| PROVIDER: | wos |
| PUBMED: | 31339635 |
| DOI: | 10.1111/ajco.13186 |
| Notes: | Meeting Abstract: abs124 -- Source: Wos |
